Literature DB >> 26010762

Explaining pharmacophobia and pharmacophilia in psychiatric patients: relationship with treatment adherence.

Carlos De Las Cuevas1, Wenceslao Peñate2.   

Abstract

OBJECTIVE: The objective of this study is to assess psychiatric patient attitudes towards psychotropic medication and their association with adherence, as well as to identify the factors that influence these attitudes.
METHODS: Nine hundred and forty nine consecutive psychiatric outpatients categorized as "pharmacophobic" or "pharmacophilic" according to the Drug Attitude Inventory were compared with regard to adherence to prescribed treatment, socio-demographic variables, clinical characteristics, health locus of control, self-efficacy, and psychological reactance.
RESULTS: Seventy three per cent of psychiatric outpatients showed a "pharmacophilic" attitude and 15.5% "pharmacophobic" one. Patients' attitudes toward prescribed drug treatment were clearly related to self-reported treatment adherence. The pharmacophobic group registered significant worse adherence than the pharmacophilic patients. Psychiatric patients' attitudes to drugs were mediated by external health locus of control, cognitive psychological reactance, and self-efficacy.
CONCLUSION: The encouragement of psychiatric patients' treatment adherence needs to include lack of coercion during prescription, a positive relationship with the prescriber, verbal persuasion, information containing vicarious experience, and the involvement of the patient in treatment decisions.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  adherence; drug attitude; health locus of control; psychiatry outpatients

Mesh:

Substances:

Year:  2015        PMID: 26010762     DOI: 10.1002/hup.2487

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  11 in total

1.  Prediction of Corresponding Dose of Transdermal Blonanserin to Oral Dose Based on Dopamine D2 Receptor Occupancy: Unique Characteristics of Blonanserin Transdermal Patch.

Authors:  Yoshiko Tomita; Takeshi Takagaki; Atsushi Kitamura; Erika Wada; Hironori Nishibe; Amane Tateno; Yoshiro Okubo
Journal:  J Clin Psychopharmacol       Date:  2022-04-05       Impact factor: 3.118

2.  Treatment-related decisional conflict in patients with depressive and anxious disorders.

Authors:  Carlos De Las Cuevas; Ramsés Marrero; Casimiro Cabrera
Journal:  Patient Prefer Adherence       Date:  2016-06-10       Impact factor: 2.711

3.  Assessment of impact of pharmacophilia and pharmacophobia on medication adherence in patients with psychiatric disorders: A cross-sectional study.

Authors:  Mini Johnson Christudas; Balaji Sathyanarayana Gupta; Krishna Undela; Noel M Isaac; Dushad Ram; Madhan Ramesh
Journal:  Indian J Pharmacol       Date:  2016 Nov-Dec       Impact factor: 1.200

4.  Factors influencing adherence to psychopharmacological medications in psychiatric patients: a structural equation modeling approach.

Authors:  Carlos De Las Cuevas; Jose de Leon; Wenceslao Peñate; Moisés Betancort
Journal:  Patient Prefer Adherence       Date:  2017-03-28       Impact factor: 2.711

5.  Skepticism and pharmacophobia toward medication may negatively impact adherence to psychiatric medications: a comparison among outpatient samples recruited in Spain, Argentina, and Venezuela.

Authors:  Carlos De Las Cuevas; Mariano Motuca; Trino Baptista; Jose de Leon
Journal:  Patient Prefer Adherence       Date:  2018-02-20       Impact factor: 2.711

6.  Predictors of pharmacophobia.

Authors:  Ana Petelinšek; Anita Lauri Korajlija
Journal:  Health Psychol Res       Date:  2020-05-26

7.  Development and validation of the Patient's Health Belief Questionnaire on Psychiatric Treatment.

Authors:  Carlos De Las Cuevas; Jose de Leon
Journal:  Patient Prefer Adherence       Date:  2019-04-10       Impact factor: 2.711

8.  Attitudes towards psychopharmacology and psychotherapy in psychiatric patients with and without migration background.

Authors:  Eva J Brandl; Nora Dietrich; Nicoleta Mell; Johanna G Winkler; Stefan Gutwinski; H Joachim Bretz; Meryam Schouler-Ocak
Journal:  BMC Psychiatry       Date:  2020-04-17       Impact factor: 3.630

9.  Predictive validity of the Sidorkiewicz instrument in Spanish: Assessing individual drug adherence in psychiatric patients.

Authors:  Carlos De Las Cuevas; Wenceslao Peñate; José Manuel García de Cecilia; Jose de Leon
Journal:  Int J Clin Health Psychol       Date:  2017-12-11

10.  Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study.

Authors:  Nakao Iwata; Jun Ishigooka; Ichiro Naoi; Masahiro Matsumoto; Yuichi Kanamori; Hiroshi Nakamura; Teruhiko Higuchi
Journal:  CNS Drugs       Date:  2020-01       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.